Company Description
Synergy CHC Corp. (NASDAQ: SNYR) is a healthcare-focused consumer products company that develops and markets consumer health and wellness brands. According to its public disclosures, Synergy positions itself as a consumer health and wellness company with a portfolio led by its flagship brands FOCUSfactor® and Flat Tummy®. The company is incorporated in Nevada and its common stock is listed on the Nasdaq Stock Market under the symbol SNYR.
Synergy CHC Corp. focuses on brain health, functional wellness, and women’s wellness and weight management. FOCUSfactor® is described in company materials as a clinically studied brain health supplement and functional beverage line with a long operating history. The brand includes dietary supplements and FOCUSfactor® Focus + Energy ready-to-drink functional beverages and brain-health energy shots. Flat Tummy® complements this portfolio as a lifestyle brand focused on women’s wellness and weight management.
Business model and distribution
Synergy CHC Corp. generates revenue from product sales, as reflected in its financial statements, and has also reported license revenue in prior periods. The company’s disclosures emphasize the marketing and distribution of consumer-branded products in the health and wellness space. FOCUSfactor® has established distribution in the United States, Canada, and the United Kingdom through major retailers. Company press releases note placements with Costco, Walmart, Amazon, BJ’s, Walgreens, and other mass, grocery, pharmacy, convenience, wholesale, and e‑commerce channels.
In addition to supplements, Synergy is building a functional beverage platform around FOCUSfactor® Focus + Energy drinks and brain-health shots. The company has entered into multiple Direct Store Delivery (DSD) partnerships with regional beverage distributors to expand retail availability of its beverages. Examples disclosed in press releases include agreements with Pine State Beverage in Maine, Fuhrer Beverage Company and Banko Beverage Co. in Pennsylvania, C&M Sales in Arkansas, Atlantic Importing Company in Southern New England, and AlaBev in Alabama. These distributors service grocery, convenience, specialty retail, and other outlets across their territories.
Geographic reach and channels
Company communications describe FOCUSfactor® as having an established footprint in the U.S., Canada, and the U.K., with ongoing expansion into additional markets. In North America, Synergy highlights retail authorizations and distribution partnerships with Kroger, Wakefern Food Corp. (parent of ShopRite and The Fresh Grocer), Uniprix in Canada, Fortinos, and Pilot Flying J. Internationally, a partnership with PriceSmart Inc. is expected to bring FOCUSfactor® Focus + Energy beverages to warehouse clubs across Central America, the Caribbean, and Colombia, according to company press releases.
Synergy has also reported the establishment of a wholly owned subsidiary in Mexico and initial shipments of its supplement products to Costco Mexico, as part of an international growth strategy focused on Mexico and broader Latin America. A Director of Sales & Marketing for Mexico & Latin America has been appointed to lead commercial strategy, market expansion, and go‑to‑market execution in that region.
Financial reporting and public company status
Synergy CHC Corp. is a smaller reporting company under U.S. securities laws, as disclosed in its registration statement on Form S‑1. The company files periodic and current reports with the U.S. Securities and Exchange Commission (SEC), including Form 10‑Q, Form 10‑K, and Form 8‑K. In its third quarter 2025 press release, Synergy reported product sales revenue, gross profit, operating income, net income, and non‑GAAP metrics such as EBITDA and Adjusted EBITDA. The company has also disclosed a public offering of common stock completed in August 2025, with proceeds intended for working capital and general corporate purposes.
Synergy’s financial disclosures emphasize ongoing profitability over multiple consecutive quarters, gross margin performance, and changes in working capital, inventory, and liabilities. The company also reports on non‑cash items, foreign currency adjustments, and stock‑based compensation as part of its reconciliation of GAAP to non‑GAAP measures.
Corporate governance and capital structure
Synergy CHC Corp. is incorporated in Nevada. Its SEC filings describe a Board of Directors and standard public company governance structures, including an Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. In 2025, stockholders approved an amendment to the company’s 2024 Equity Incentive Plan to increase the number of shares available for issuance and an amendment to the Articles of Incorporation authorizing up to 1,000,000 shares of preferred stock. The company has also reported changes in board composition and executive roles, such as the appointment of a Head of Strategic Partnerships and a new director with extensive retail and pharmacy OTC experience.
Synergy’s capital structure includes common stock listed on Nasdaq under the symbol SNYR, and it has issued warrants to an underwriter in connection with a public offering, as described in its Form 8‑K. The company has discussed the use of equity incentives and underwriter warrants in its SEC filings and registration statements.
Brand positioning and recognition
Within the consumer health and wellness category, Synergy emphasizes brain health and cognitive performance as a core focus. FOCUSfactor® is described as a clinically studied brain health supplement with formulations aimed at memory, focus, and cognitive clarity. Company press releases state that FOCUSfactor® has a long legacy in the category and has been recognized as the #1 Pharmacist Recommended OTC Memory Supplement for 2025–2026 in a Pharmacy Times survey of pharmacists’ over‑the‑counter recommendations.
Synergy’s communications also highlight its strategy to expand FOCUSfactor® into the functional beverage market, with products positioned around clean energy, mental clarity, and brain‑health benefits. The company describes its beverages as part of the broader trend toward functional wellness and performance‑oriented consumer products. Flat Tummy® is presented as a lifestyle brand that broadens Synergy’s reach into women’s wellness and weight management.
Stock information and investor focus
Investors researching SNYR stock can find details about Synergy CHC Corp.’s operations, risk factors, and financial condition in its SEC filings, including its Form S‑1 registration statement and subsequent reports. The company identifies key risks related to competition in the consumer health and wellness market, reliance on third‑party manufacturers and suppliers, regulatory requirements for nutritional supplements, product safety and quality perceptions, and its ability to execute on expansion plans and maintain brand reputation.
Because Synergy operates in the consumer health and wellness sector with a focus on branded products, its performance is closely tied to retail distribution, brand recognition, and consumer demand for brain health, functional beverages, and women’s wellness products. Public disclosures emphasize the importance of retail partnerships, distribution networks, and international expansion in the company’s growth strategy.
Stock Performance
Synergy Chc (SNYR) stock last traded at $0.5246, down 2.96% from the previous close. Over the past 12 months, the stock has lost 78.9%. At a market capitalization of $5.7M, SNYR is classified as a micro-cap stock with approximately 11.5M shares outstanding.
Latest News
Synergy Chc has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, conferences, earnings date, partnership. View all SNYR news →
SEC Filings
Synergy Chc has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form PRE 14A, 1 Form 10-K, 1 Form NT 10-K. The most recent filing was submitted on April 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SNYR SEC filings →
Financial Highlights
Synergy Chc generated $30.4M in revenue over the trailing twelve months, retaining a 66.8% gross margin, operating income reached -$8.5M (-27.8% operating margin), and net income was -$12.3M, reflecting a -40.6% net profit margin. Diluted earnings per share stood at $-1.27. The company generated -$2.6M in operating cash flow. With a current ratio of 1.22, the company maintains adequate short-term liquidity.
Upcoming Events
Increase principal payments
Synergy Chc has 2 upcoming scheduled events. The next event, "Increase principal payments", is scheduled for January 1, 2027 (in 257 days). 2 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the SNYR stock price.
Short Interest History
Short interest in Synergy Chc (SNYR) currently stands at 48.9 thousand shares, down 12.5% from the previous reporting period, representing 1.0% of the float. Over the past 12 months, short interest has decreased by 77%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Synergy Chc (SNYR) currently stands at 2.5 days, down 9.5% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 148% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.2 days.
SNYR Company Profile & Sector Positioning
Synergy Chc (SNYR) operates in the Medical Distribution industry within the broader Medicinal Chemicals & Botanical Products sector and is listed on the NASDAQ.
Investors comparing SNYR often look at related companies in the same sector, including Cosmos Health Inc. (COSM), Zynex Inc (ZYXI), 111 (YI), Quipt Home Medical Corp (QIPT), and Edap Tms (EDAP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SNYR's relative position within its industry.